SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

FOTIADES GEORGE L

(Last)

(First)

(Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN

43017

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President & COO

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2001

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	10/15/2001		P		5	A	$74	80,244	D
Common Shares	01/15/2002		P⁽¹⁾		7	A	$61.6	80,251	D
Common Shares	04/15/2002		P		6	A	$68.7	80,257	D
Common Shares	07/15/2002		P⁽¹⁾		8	A	$52.9	80,265	D
Common Shares	10/15/2002		P⁽¹⁾		6	A	$63	80,271	D
Common Shares	01/15/2003		P		7	A	$61.86	80,278	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Option (right to buy)⁽²⁾	$41.553							09/16/2001	09/16/2008	Common Shares	56,250		1	D
Option (right to buy)⁽²⁾	$47.333							03/01/2002	03/01/2009	Common Shares	27,171		1	D
Option (right to buy)⁽²⁾	$31.167							11/15/2002	11/15/2009	Common Shares	67,907		1	D
Option (right to buy)⁽²⁾	$66.083							11/20/2003	11/20/2010	Common Shares	60,530		1	D
Option (right to buy)⁽²⁾	$68.1							11/19/2004	11/19/2011	Common Shares	67,915		1	D
Option (right to buy)⁽²⁾	$67.9							11/18/2005	11/18/2012	Common Shares	250,000		1	D
Option (right to buy)⁽²⁾	$64.11							01/31/2007	02/01/2014	Common Shares	225,000		1	D

Explanation of Responses:

1. These transactions were each matchable with the sale of 4,144 shares at $68.586 per share on 4/29/02, which resulted in an aggregate Section 16 profit of $204.33. Details of the calculation of the aggregate Section 16 profit are as follows: 6.648 shares purchased on 1/15/02 multiplied by the $6.986 spread between the matchable sale price and purchase price for a Section 16 profit of $46.45; 7.747 shares purchased on 7/15/02 multiplied by the $15.686 spread between the matchable sale price and the purchase price for a Section 16 profit of $121.52; and 6.508 shares purchased on 10/15/02 multiplied by the $5.586 spread between the matchable sale price and the purchase price for a Section 16 profit of $36.36. The reporting person has remitted a check to the Company in the full amount of the aggregate Section 16 profit.

2. Stock option granted pursuant to the Cardinal health, Inc. Equity Incentive Plan.

Remarks:

	George L. Fotiades	02/09/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.